Stay updated on DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.

Latest updates to the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page
- Check3 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page displays a new 'Results Submitted' indicator and the updated revision 'v3.4.2', while removing the older 'No Results Posted' notice and the previous revision 'v3.4.1'.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, with guidance to cc.nih.gov and opm.gov. Updated revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check68 days agoChange DetectedUI updates include adding a 'Show glossary' option, capitalization changes to the QC-related labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new revision note 'Revision: v3.4.0' replacing 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.